☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
autoimmune disease
Selecta Enters into an Exclusive License Agreement with Genovis to Advance IgG Protease in Gene Therapy and Autoimmune Disease
October 22, 2021
FibroGen Collaborates with HiFiBiO to Advance Next-Generation Therapies for Patients with Cancer and Autoimmune Disease
June 21, 2021
Takeda and KSQ Collaborate to Develop and Commercialize Novel Immuno-Oncology Therapies
January 15, 2021
Henlius Receives the NMPA's Approval for HLX03 (biosimilar- adalimumab) to Treat Autoimmune Disease
December 7, 2020
Henlius Present Results of HLX03 (biosimilar- adalimumab) in P-lll Study for Plaque Psoriasis at EADV 2020
October 29, 2020
Innovent and Lilly's Halpryza (biosimilar- rituximab) Receive NMPA's Approval in China
October 12, 2020
Load more...
Back to Home
Modal title
×
Modal body text goes here.